Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Haemonetics Corp. (HAE)
NYSE:HAE
Earnings Data
Report Date
May 13, 2025TBA Not Confirmed
Period Ending
2025 (Q4)Consensus EPS Forecast
1.22Last Year’s EPS
0.9Same Quarter Last Year
Moderate Buy
Based on 9 Analysts Ratings
---
Earnings Call Summary
Earnings Call Date:Feb 06, 2025
|% Change Since: -10.93%
|Next Earnings Date:May 13, 2025
Earnings Call Sentiment|Neutral
The earnings call presented a mixed picture with strong growth in the hospital and interventional technologies segments offset by declines in plasma revenue and challenges in China. The company's ability to secure new long-term agreements and record operating margins are positive signs, but the issues with cash flow and certain product lines indicate areas needing improvement.Company Guidance
During Haemonetics' third quarter fiscal year 2025 call, the company provided updated guidance for the fiscal year. Revenue for the third quarter was reported at $349 million, indicating a 4% growth on a reported basis but flat growth organically. The company highlighted its adjusted earnings per share, which increased by 14% to $1.19. The hospital business unit, now the largest segment, showed impressive revenue growth of 24% on a reported basis and 12% organically for the quarter. In contrast, the Plasma business faced a revenue decline of 9% in the quarter due to the planned transition with CSL, although excluding CSL, U.S. disposables revenue saw growth. The company updated its guidance, projecting hospital revenue growth between 24% to 26% on a reported basis and a 5% to 7% decline in organic plasma revenue. Despite these adjustments, Haemonetics remains confident in its strategy, emphasizing sustainable long-term growth and margin expansion, with third-quarter adjusted operating income reaching a record 25.7% of revenue.Hospital Segment Growth
Hospital revenue grew 24% on a reported basis in the third quarter and 28% year-to-date, with organic growth of 12% and 14%, respectively. Blood Management Technologies revenue grew 10% in the quarter and 11% year-to-date.
Interventional Technologies Performance
Interventional Technologies grew 47% in the third quarter and 58% year-to-date on a reported basis with 16% organic growth in the third quarter and 18% growth year-to-date.
Vascular Closure Growth
Growth in Vascular Closure was driven by leadership in electrophysiology, where revenue from VASCADE MVP and VASCADE MVP XL grew in the mid-20s, both in the quarter and year-to-date.
Record Operating Margin
Adjusted operating income for the third quarter was $89.4 million, a $16.1 million increase or 25.7% of revenue, a new company record.
New Long-term Agreements
Signed new long-term agreements with BioLife and Grifols, centered around gaining market share through adoption of winning technology.
---
HAE Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
---
HAE Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
| Feb 06, 2025 | $71.24 | $62.99 | -11.58% |
| Nov 07, 2024 | $78.16 | $86.53 | +10.71% |
| Aug 08, 2024 | $85.72 | $76.43 | -10.84% |
| May 09, 2024 | $93.25 | $92.60 | -0.70% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
---
FAQ
When does Haemonetics Corp. (HAE) report earnings?
Haemonetics Corp. (HAE) is schdueled to report earning on May 13, 2025, TBA Not Confirmed.
What is Haemonetics Corp. (HAE) earnings time?
Haemonetics Corp. (HAE) earnings time is at May 13, 2025, TBA Not Confirmed.
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is HAE EPS forecast?
HAE EPS forecast for the fiscal quarter 2025 (Q4) is 1.22.
---